期刊文献+

血浆SP1、sFlt1、Ghrelin与早发型重度子痫前期患者胎儿生长受限的关系分析 被引量:1

Relationship between plasma SP1, sFlt1 and Ghrelin and fetal growth restriction in patients with early-onsetsevere preeclampsia
下载PDF
导出
摘要 目的分析血浆妊娠特异性β_(1)糖蛋白(SP1)、可溶性FMS样酪氨酸激酶-1(sFlt1)、生长激素释放肽(Ghrelin)与早发型重度子痫前期患者胎儿生长受限(FGR)的关系.方法回顾性分析我院2018年9月至2020年9月收治的73例早发型重度子痫前期患者的临床资料,根据胎儿生长受限情况将其分为FGR组(n=41)和非FGR组(n=32),对比两组孕妇血浆SP1、sFlt1、Ghrelin水平,采用Pearson相关性分析血浆SP1、sFlt1、Ghrelin水平与胎儿体质量的相关性,采用ROC曲线分析血浆SP1、sFlt1、Ghrelin对早发型重度子痫前期患者胎儿生长受限的预测效能.结果FGR组血浆SP1水平明显低于非FGR组(P<0.05),FGR组血浆sFlt1、Ghrelin水平明显高于非FGR组(P<0.05).胎儿体质量与血浆sFlt1、Ghrelin呈负相关(P<0.05),与血浆SP1呈正相关(P<0.05).SP1、sFlt1、Ghrelin曲线AUC明显大于参考线(P<0.05),其cut-off值为95.88mg/L、33.83μg/L、16.54μg/L.结论血浆SP1、sFlt1、Ghrelin与早发型重度子痫前期患者FGR关系紧密,血浆SP1、sFlt1、Ghrelin水平还能有效预测FGR的发生,具有较高临床检测价值. Objective To analyze the relationship of plasma pregnancy-specific β1 glycoprotein(SP1),soluble FMS-like tyrosine kinase-1(sFlt1) and growth hormone releasing peptide(Ghrelin)with fetal growth restriction(FGR) in patients with early-onset severe preeclampsia.Methods The clinical data of 73 patients with early-onset severe preeclampsia who were treated in the hospital between September 2018 and September 2020 were retrospectively analyzed, and the patients were divided into FGR group(n=41) and non-FGR group(n=32)according to fetal growth restriction.The levels of plasma SP1,sFlt1 and Ghrelin were compared between the two groups of pregnant women.Pearson correlation analysis was used to analyze the correlation between plasma SP1,sFlt1 and Ghrelin levels and fetal body mass, and ROC curve was adopted to analyze the predictive efficiency of plasma SP1,sFlt1,and Ghrelin on fetal growth restriction in patients with early-onset severe preeclampsia.Results The plasma SP1 level in FGR group was significantly lower than that in non-FGR group(P<0.05) while the plasma sFlt1 and Ghrelin levels were significantly higher than those in non-FGR group(P<0.05).Fetal body mass was negatively correlated with plasma sFlt1 and Ghrelin(P<0.05),and was positively correlated with plasma SP1(P<0.05).The AUCs of SP1,sFlt1 and Ghrelin curves were significantly larger than the reference lines(P<0.05),and the cut-off values were 95.88 mg/L,33.83 μg/L and 16.54 μg/L.Conclusion Plasma SP1,sFlt1 and Ghrelin are closely related to FGR in patients with early-onset severe preeclampsia.Plasma SP1,sFlt1 and Ghrelin levels can also effectively predict the occurrence of FGR and have high clinical detection value.
作者 钟丽莉 ZHONG Lili(Department of Obstetrics,Fnjian Province Longyan People's Hospital,Longyan,Fujian 364000 China)
出处 《福建医药杂志》 CAS 2022年第6期37-40,共4页 Fujian Medical Journal
关键词 妊娠特异性Β1糖蛋白 可溶性FMS样酪氨酸激酶-1 生长激素释放肽 早发型重度子痫前期 胎儿生长受限 pregnancy-specificβ1 glycoprotein soluble FMS-like tyrosine kinase-1 growth hormone releasing peptide early-onset severe preeclampsia fetal growth restriction
  • 相关文献

参考文献8

二级参考文献79

  • 1关悦,乔虹.同型半胱氨酸与糖尿病肾病的相关性研究[J].医学研究生学报,2011,24(5):547-549. 被引量:14
  • 2杨孜,李蓉,石凌懿,王丽娜,叶蓉华,王荣,黄萍.早发型重度先兆子痫的临床界定及保守治疗探讨[J].中华妇产科杂志,2005,40(5):302-305. 被引量:333
  • 3杨孜,王伽略,黄萍,石凌懿,李蓉,叶蓉华,陈蕾.重度子痫前期临床发病类型及特点与围产结局的关系[J].中华妇产科杂志,2006,41(5):302-306. 被引量:155
  • 4Wessel G, Annelies R, Gouke J, et al. A ramdomised controlled tri- al comparing two temporizing management strategies, one with and one without plasma volume expansion, for severe and early onset preeclampsia[ J]. BJOG,2005,112(10) :1358-1368.
  • 5Reis ZS, Lage EM, Teixeira PG, et al. Early onset preeclamsia: is it a better classification for maternal and perinatal outcomes [ J ]. Rev Bras Gynecol Obstet,2010,32 (12) : 584-590.
  • 6Catov JM, Ness RB, Kip KE, et al. Risk of early or severe pre- eclampsia related to pre-existing conditions [ J ]. Int J Epidemiol, 2007,36(2) :412-419.
  • 7Norwitz ER, Funal EF. Expectant management of severe preeelam- sia remote from term : hope for the best, but expect the worst [ J ]. Am J Obstet Gynecol, 2008,199 ( 3 ) :209 -212.
  • 8Abdel-Hady el-S, Fawzy M, EI-Negeri M, et al. Is expectant man- agement of early-onset severe preeclampsia worthwhile in low-re- source settings[ J]. Arch Gynecol Obstet,2010,282( 1 ) :23-27.
  • 9Sibai BM, Barton JR. Expectant management of severe preeclamp- sia remote from term: patient selection, treatment, and delivery in- dications [ J ]. Am J Obstet Gynecol,2007,196 (6) :514.
  • 10Heilmann L, Rath W, Pollw K. Hemorheological changes in women with severe preeclampsia[ J ]. Clin Hemorheol Microcirc ,2004,31 ( 1 ) :49-58.

共引文献79

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部